title: Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter.
abstract: Quantitative analysis of (1)H-magnetic resonance spectroscopic imaging (MRSI) data was developed using the user-independent spectral analysis routine LCModel. Tissue segmentation was performed using statistical parametric mapping software (SPM 96), and the results were used to correct for cerebrospinal fluid contamination. A correction was developed for the imperfections in the spectroscopic excitation profile in order to improve the uniformity of metabolite images. After validation in phantoms, these techniques were applied to study differences in metabolite concentrations between gray and white matter in normal volunteers (n = 13). A positive correlation was found between concentration and gray matter content for most metabolites studied. The estimated ratios of metabolite concentration in gray vs. white matter were: N-acetyl aspartate + N-acetyl aspartyl glutamate (NAc) = 1.16+/- 0.11; creatine = 1.7+/-0.3; glutamate + glutamine = 2.4+/-0.5; myo-inositol = 1.6+/-0.3; choline = 0.9+/-0.2. The ratio of NAc/Cr was negatively correlated with gray matter content: gray/white = 0.69 +/-0.08. These methods will be useful in the evaluation of metabolite concentrations in MRSI voxels with mixed tissue composition in patient groups.
authors.affiliation: MRI Unit, National Society for Epilepsy, Chalfont St. Peter, Buckinghamshire, UK.
authors.forename: M A
authors.initials: MA
authors.lastname: McLean
authors.forename: F G
authors.initials: FG
authors.lastname: Woermann
authors.forename: G J
authors.initials: GJ
authors.lastname: Barker
authors.forename: J S
authors.initials: JS
authors.lastname: Duncan
mesh_terms: D000328:Adult; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000032:analysis; D001921:Brain / Q000002:abnormalities / Q000033:anatomy & histology / Q000378:metabolism*; D001923:Brain Chemistry; D002138:Calibration; D002555:Cerebrospinal Fluid / Q000737:chemistry; D002794:Choline / Q000032:analysis; D003401:Creatine / Q000032:analysis; D004151:Dipeptides / Q000032:analysis; D004827:Epilepsy / Q000175:diagnosis; D005260:Female; D018698:Glutamic Acid / Q000032:analysis; D005973:Glutamine / Q000032:analysis; D006801:Humans; D007294:Inositol / Q000032:analysis; D019344:Lactic Acid / Q000032:analysis; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000175:diagnosis; D019047:Phantoms, Imaging; D012044:Regression Analysis; D012680:Sensitivity and Specificity
chemical_list: D004151:Dipeptides; D005973:Glutamine; C027172:isospaglumic acid; D001224:Aspartic Acid; D019344:Lactic Acid; D018698:Glutamic Acid; D007294:Inositol; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline